Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2,4-Dihydroxy-6-methoxyquinoline is a chemical compound belonging to the quinoline family, characterized by the presence of two hydroxyl groups and a methoxy group attached to the quinoline ring. It has been studied for its potential biological and pharmacological activities, including antioxidant and anti-inflammatory properties, and its potential use as a drug target for treating various diseases. 2,4-DIHYDROXY-6-METHOXYQUINOLINE also shows promise in the synthesis of pharmaceuticals and as a building block for heterocyclic compounds with pharmaceutical applications, highlighting its importance in drug discovery and development.

14300-45-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 14300-45-9 Structure
  • Basic information

    1. Product Name: 2,4-DIHYDROXY-6-METHOXYQUINOLINE
    2. Synonyms: 2,4-DIHYDROXY-6-METHOXYQUINOLINE;4-HYDROXY-6-METHOXY-1H-QUINOLIN-2-ONE;SPECS AE-562/12222655;4-hydroxy-6-methoxyquinolin-2(1H)-one;2(1H)-Quinolinone,4-hydroxy-6-methoxy-
    3. CAS NO:14300-45-9
    4. Molecular Formula: C10H9NO3
    5. Molecular Weight: 191.18
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 14300-45-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 360.8°Cat760mmHg
    3. Flash Point: 172°C
    4. Appearance: /
    5. Density: 1.355g/cm3
    6. Vapor Pressure: 7.8E-06mmHg at 25°C
    7. Refractive Index: 1.623
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. CAS DataBase Reference: 2,4-DIHYDROXY-6-METHOXYQUINOLINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2,4-DIHYDROXY-6-METHOXYQUINOLINE(14300-45-9)
    12. EPA Substance Registry System: 2,4-DIHYDROXY-6-METHOXYQUINOLINE(14300-45-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 14300-45-9(Hazardous Substances Data)

14300-45-9 Usage

Uses

Used in Pharmaceutical Industry:
2,4-Dihydroxy-6-methoxyquinoline is used as a building block for the synthesis of various pharmaceuticals due to its unique chemical structure and potential biological activities.
Used in Drug Discovery and Development:
2,4-DIHYDROXY-6-METHOXYQUINOLINE is utilized as a potential drug target for the treatment of various diseases, given its antioxidant and anti-inflammatory properties, as well as its potential role in modulating biological pathways related to disease progression.
Used in Heterocyclic Compounds Production:
2,4-Dihydroxy-6-methoxyquinoline serves as a key component in the production of heterocyclic compounds with potential pharmaceutical applications, contributing to the development of novel therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 14300-45-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,3,0 and 0 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 14300-45:
(7*1)+(6*4)+(5*3)+(4*0)+(3*0)+(2*4)+(1*5)=59
59 % 10 = 9
So 14300-45-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H9NO3/c1-14-6-2-3-8-7(4-6)9(12)5-10(13)11-8/h2-5H,1H3,(H2,11,12,13)

14300-45-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-Dihydroxy-6-methoxyquinoline

1.2 Other means of identification

Product number -
Other names 4-hydroxy-6-methoxy-1H-quinolin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14300-45-9 SDS

14300-45-9Relevant articles and documents

Identification and molecular modeling of new quinolin-2-one thiosemicarbazide scaffold with antimicrobial urease inhibitory activity

Elbastawesy, Mohammed A. I.,El-Shaier, Yaseen A. M. M.,Ramadan, Mohamed,Brown, Alan B.,Aly, Ashraf A.,Abuo-Rahma, Gamal El-Din A.

, p. 13 - 27 (2020/01/22)

Abstract: A new series of 6-substituted quinolin-2-one thiosemicarbazides 6a–j has been synthesized. The structure of the target compounds was proved by different spectroscopic and elemental analyses. All the designed final compounds were evaluated for their in vitro activity against the urease-producing R. mucilaginosa and Proteus mirabilis bacteria as fungal and bacterial pathogens, respectively. Moreover, all compounds were in vitro tested as potential urease inhibitors using the cup-plate diffusion method. Compounds 6a and 6b were the most active with (IC50 = 0.58 ± 0.15 and 0.43 ± 0.09?μM), respectively, in comparison with lead compound I (IC50 = 1.13 ± 0.00?μM). Also, the designed compounds were docked into urease proteins (ID: 3LA4 and ID: 4UBP) using Open Eye software to understand correctly about ligand–receptor interactions. The docking results revealed that the designed compounds can interact with the active site of the enzyme through multiple strong hydrogen bonds. Moreover, rapid overlay of chemical structures’ analysis was described to understand the 3D QSAR of synthesized compounds as urease inhibitors. The results emphasize the importance of polar thiosemicarbazide directly linked to 6-substituted quinolone moieties as promising antimicrobial urease inhibitors. Graphic abstract: [Figure not available: see fulltext.]

New Quinoline-2-one/thiazolium bromide Derivatives; Synthesis, Characterization and Mechanism of Formation

Mostafa, Sara M.,Aly, Ashraf A.,Sayed, Samia M.,Raslan, Mohamed A.,Ahmed, Amira E.,Nafady, Ayman,Ishak, Esam A.,Shawky, Ahmed M.,Abdelhafez, El-Shimaa M.N.

, (2021/05/10)

We report on the formation of new quinoline-2-one derived by thiazolium bromides from the reaction of 3-thiosemicarbazides derived by 2-quinolones with 2-bromoacetophenones. The structure of products was elucidated by mass, IR and NMR spectra together with elemental analysis. The mechanism of products formation was discussed.

Method for preparing 4-hydroxyquinolin-2(1H)-one compound

-

Paragraph 0070-0072, (2021/09/22)

The invention discloses a method for preparing a 4-hydroxyquinolin-2(1H)-one compound, which comprises the following steps of: reacting 2-ethynylaniline as shown in a formula (1) and carbon dioxide which are used as raw materials in an ionic liquid in the presence of a silver salt catalyst to obtain the 4-hydroxyquinoline-2 (1H)-one compound as shown in a formula (II). The reaction equation is shown in the specification. When the method disclosed by the invention is applied to the reaction for preparing the 4-hydroxyquinolin-2(1H)-one compound, the reaction conditions are relatively mild, the dosage of the silver salt catalyst is small, the separation and purification process of the product is relatively simple, the product yield is high, and the application range of a substrate is wide.

Mild, efficient, and solvent-free synthesis of 4-hydroxy-2-quinolinones

Amagata, Taro,Assad, Meerna Y.,Atalay, Sanberk S.,Wu, Weiming

, (2020/03/05)

Malonic acid monoanilides were obtained in excellent yield from the reaction of anilines with Meldrum's acid under solvent-free conditions. The malonic acid monoanilide intermediates were then treated with methanesulfonic acid anhydride (MSAA) to produce 4-hydroxy-2-quinolinones in excellent yield. It should be noted that both reactions had to be run under mild conditions to avoid the decarboxylation of the malonic acid monoanilide intermediate.

Synthesis and colon anticancer activity of some novel thiazole/-2-quinolone derivatives

Aly, Ashraf A.,Mohamed, Asmaa H.,Ramadan, Mohamed

, (2020/02/13)

We direct for the synthesis of 1,6,7-trisubstituted-4-phenylthiazol-2(3H)-ylidene)hydrazono)methyl)quinolin-2-one derivatives by the reaction of corresponding thiosemicarbazone derived by 2-quinolone derivatives with 2-bromoacetophenones in presence of triethylamine at room temperature. The mechanism of the formed products was discussed. The structure of the obtained products was fully characterized using different spectral techniques including infrared (IR), nuclear magnetic resonance (NMR), and mass spectrometry (MS) together with elemental analyses. The new synthesized compounds showed a moderate colon anticancer activity.

Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors

Elbastawesy, Mohammed A.I.,Aly, Ashraf A.,Ramadan, Mohamed,Elshaier, Yaseen A.M.M.,Youssif, Bahaa G.M.,Brown, Alan B.,El-Din A Abuo-Rahma, Gamal

, (2019/06/19)

Two new series of diethyl 2-[2-(substituted-2-oxo-1,2-dihydroquinolin-4-yl)hydrazono]-succinates 6a-g and 1-(2-oxo-1,2-dihydroquinolin-4-yl)-1H-pyrazoles 7a-f have been designed and synthesized. The structures of the synthesized compounds were proved by IR, mass, NMR (2D) spectra and elemental analyses. The target compounds were evaluated for their in vitro cytotoxic activity against 60 cancer cell lines according to NCI protocol. Consequently, seven compounds were further examined against the most sensitive cell lines, leukemia CCRF-CEM, and MOLT-4. 5-Amino-1-(6-bromo-2-oxo-1,2-dihydroquinolin-4-yl)-1H-pyrazole-3,4-dicarbonitrile (7f) was the most active product, with IC50 = 1.35 uM and 2.42 uM against MOLT-4 and CCRF-CEM, respectively. Also, it showed a remarkable inhibitory activity compared to erlotinib on the EGFR TK with IC50 = 247.14 nM and 208.42 nM, respectively. Cell cycle analysis of MOLT-4 cells treated with 7f showed cell cycle arrest at G2/M phase (supported by Caspases, BAX and Bcl-2 studies) with a significant pro-apoptotic activity as indicated by annexin V-FITC staining. Moreover, the docking study indicated that both the pyrazole moiety and the quinolin-2-one ring showed good fitting into EGFR (PDB code: 1M17). In order to interpret SAR of the designed compounds, and provide a basis for further optimization, molecular docking of the synthesized compounds to known EGFR inhibitors was performed. The study illustrated the effect of several factors on the compounds’ activity.

Synthesis and structure elucidation of some new azo dye from hydroxyquinolin-2(1H)-one derivatives and their antimicrobial evaluation

Ghoneim, Amira A.,Morsy, Nesrin M.

, p. 2567 - 2572 (2018/09/13)

The aim of the work is synthesis of some novel azo dye from 1,2-dihydro-4-hydroxy-2-oxoquinoline-6-sulfonic acid (3), 4-hydroxy-6-methoxyquinolin-2(1H)-one (4), and 4-hydroxy-6-nitroquinolin-2(1H)-one (5). The prepared compounds were screened for antibact

Synthesis and SAR studies of novel 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives for anticancer activity

Chen, Yi-Fong,Lin, Yi-Chien,Morris-Natschke, Susan L.,Wei, Chen-Fang,Shen, Ting-Chen,Lin, Hui-Yi,Hsu, Mei-Hua,Chou, Li-Chen,Zhao, Yu,Kuo, Sheng-Chu,Lee, Kuo-Hsiung,Huang, Li-Jiau

supporting information, p. 1195 - 1221 (2015/03/04)

Background and Purpose 4-Phenylquinolin-2(1H)-one (4-PQ) derivatives can induce cancer cell apoptosis. Additional new 4-PQ analogs were investigated as more effective, less toxic antitumour agents. Experimental Approach Forty-five 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives were synthesized. Antiproliferative activities were evaluated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliun bromide assay and structure-activity relationship correlations were established. Compounds 9b, 9c, 9e and 11e were also evaluated against the National Cancer Institute-60 human cancer cell line panel. Hoechst 33258 and Annexin V-FITC/PI staining assays were used to detect apoptosis, while inhibition of microtubule polymerization was assayed by fluorescence microscopy. Effects on the cell cycle were assessed by flow cytometry and on apoptosis-related proteins (active caspase-3, -8 and -9, procaspase-3, -8, -9, PARP, Bid, Bcl-xL and Bcl-2) by Western blotting. Key Results Nine 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives (7e, 8e, 9b, 9c, 9e, 10c, 10e, 11c and 11e) displayed high potency against HL-60, Hep3B, H460, and COLO 205 cancer cells (IC50 50 > 50 μM). Particularly, compound 11e exhibited nanomolar potency against COLO 205 cancer cells. Mechanistic studies indicated that compound 11e disrupted microtubule assembly and induced G2/M arrest, polyploidy and apoptosis via the intrinsic and extrinsic signalling pathways. Activation of JNK could play a role in TRAIL-induced COLO 205 apoptosis. Conclusion and Implications New quinolone derivatives were identified as potential pro-apoptotic agents. Compound 11e could be a promising lead compound for future antitumour agent development.

Synthesis of symmetrically substituted 3,3-dibenzyl-4-hydroxy-3,4-dihydro- 1H-quinolin-2-ones, as novel quinoline derivatives with antibacterial activity

Ferretti, Matías D.,Neto, Alexandre T.,Morel, Ademir F.,Kaufman, Teodoro S.,Larghi, Enrique L.

, p. 253 - 266 (2014/06/09)

A novel series of symmetrically substituted 3,3-dibenzyl-4-hydroxy-3,4- dihydro-1H-quinolin-2-ones was synthesized and tested as antimicrobials. The minimum inhibitory concentration (MIC) values of the most active heterocycles were slightly higher than those exhibited by levofloxacin, employed as comparator. Structural factors affecting the activity were explored along three diversification points, including the substituents of the aromatic rings of the 3-benzyl moieties, as well as the functionalization of both, the homocyclic ring of the heterocycle and the quinolonic nitrogen atom. 6-Chloro and 3,3-bis(4′-chlorobenzyl) derivatives showed the lower MIC values. Optimally substituted heterocycles were synthesized, which exhibited enhanced activity.

6-methoxy-2-oxo-1,2-dihydroquinoline-3,4-dicarbonitriles, a red compound class with solvent and pH independent green fluorescence maxima

Enoua,Lahm,Uray,Stadlbauer

, p. 492 - 501 (2014/04/17)

The sodium p-toluenesulfinate mediated reaction of potassium cyanide with 4-chlorocarbostyrils 8, 16, 18, and 23 gave in all cases the highly fluorescent and stable 6-methoxy-2-oxoquinoline-3,4-dicarbonitrile 9 (λexc 460 nm and λem 545 nm). This is remarkable, because starting carbostyrils 8, 16, 18, and 23 had a chloro substituent, a nitro substituent, an acetylamino substituent, or a piperidinyl substituent in position 3. Hence, we observed not only a substitution of the 4-chloro and expected 3-chloro substituents by the cyanide nucleophile but also an exchange of a nitro substituent, an acetylamino substituent, and a piperidinyl substituent in position 3. The multistep insertion of substituents leading to 8, 16, 18, and 23 started from 4-hydroxy-6-methoxyquinolone 4, easily obtained from p-anisidine and malonic acid. Substitutions in position 3 gave 4-hydroxy-3-nitro and 3-chloro intermediates, which were converted to 3,4-dichlorocarbostyril 8 and 4-chloro-3-nitrocarbostyril 16. Reduction of the 3-nitro intermediate led to the 3-acetylamino analog and subsequent chlorination led to 3-acetylamino-4- chlorocarbostyril 18. 4-Chloro-3-piperidinylcarbostyril 23 was obtained from intermediate 3,3-dichloroquinolinedione by subsequent amination, reduction and chlorination. Further, 3-acetylamino-4-chlorocarbostyril 18 gave with lithium p-toluenesulfinate highly fluorescent 3-amino-6-methoxy-4-p- tolylsulfonylquinolone 19.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14300-45-9